Presynaptic modulation by L-glutamate and GABA of sympathetic co-transmission in rat isolated vas deferens

British Journal of Pharmacology

Volumn 118, Issue 3, 1996, Pages 755-761

  Kwan, Yiu Wa ^a,b   Ngan, Man Piu ^a   Tsang, Kay Yan ^a   Lee, Ha Man ^a   Chu, Lai Ah ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

GABA transaminase; Glutamate decarboxylase; L glutamate; Vas deferens (rat); aminobutyric acid (GABA)

Indexed keywords

2 HYDROXYSACLOFEN; 3 MERCAPTOPROPIONIC ACID; 4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ADENOSINE TRIPHOSPHATE; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; KAINIC ACID; NORADRENALIN;

ADRENERGIC TRANSMISSION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; FEMALE; MUSCLE TWITCH; NERVE STIMULATION; NONHUMAN; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT; VAS DEFERENS;

EID: 0029951654     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15464.x     Document Type: Article

References (37)

1. ANTON, P.G., DUNCAN, M.E. & MCGRATH, J.C. (1977). An analysis of the anatomical basis for the mechanical response to motor nerve stimulation of the rat vas deferens. J. Physiol., 273, 23-43.
2. BELL, C. (1972). Autonomic nervous control of reproduction: Circulatory and other factors. Pharmacol. Rev., 24, 657-736.
3. BROWN, D.A., DOCHERTY, J.D., FRENCH, A.M., MACDONALD, A., MCGRATH, J.C. & SCOTT, N.C. (1983). Separation of adrenergic and non-adrenergic contractions to field stimulation in the rat vas deferens. Br. J. Pharmacol., 79, 379-393.
4. CURTIS, D.R., DUGGAN, A.W., FELIX, D. & JOHNSTON, G.A.R. (1970). GABA, bicuculline and central inhibition. Nature, 226, 1222-1224.
5. DALY, J.W. (1982). Adenosine receptors: targets for future drugs. J. Med. Chem., 25, 197-207.
6. ERDO, S.L., ROSDY, B. & SZPORNY, L. (1982). Higher GABA concentrations in fallopian tube than in brain of the rat. J. Neurochem., 38, 1174-1176.
7. EVANS, R.H., FRANCIS, A.A., JONES, A.W., SMITH, D.A.S. & WATKINS, J.C. (1982). The effects of a series of ω-phosphonic α-carboxylic amino acids on electrically evoked and excitant amino acid-induced responses in isolated spinal cord preparations. Br. J. Pharmacol., 75, 65-75.
8. 2+. Brain Res., 664, 252-256.
9. FERGUSON, D.R. & MARCHANT, J.S. (1995). Inhibitory actions of GABA on rabbit urinary bladder muscle strips: mediation by potassium channels. Br. J. Pharmacol., 115, 81-83.
10. FOWLER, L.J. & JOHN, R.A. (1972). Active-site-directed irreversible inhibition of rat brain 4-aminobutyrate aminotransferase by ethanolamine O-sulphate in vitro and in vivo. Biochem. J., 130, 569-573.
11. FURNESS, J.B. & IWAYAMA, T. (1972). The arrangement and identification of axons innervating the vas deferens of the guinea-pig. J. Anat., 113, 179-196.
12. GONZALES, J.M., LOEB, A.L., REICHARD, P.S. & IRVINE, S. (1995) Ketamine inhibits glutamate-, N-methyl-D-aspartate-, and quisqualate-stimulated cGMP production in cultured cerebral neurons. Anesthesiology, 82, 205-213.
13. B-receptor mediated inhibition of potassium-evoked release of endogenous 5-hydroxytryptamine from mouse frontal cortex. Br. J. Pharmacol., 91, 517-522.
14. 3H]butyric acid from cultured amacrine-like neurons mediated by different excitatory amino acid receptors. J. Neurochem., 56, 923-932.
15. KERR, D.I., ONG, J., JOHNSTON, G.A., ABBENANTE, J. & PRAGER, R.H. (1988). 2-Hydroxysaclofen: An improved antagonist at central and peripheral GABA-B receptors. Neurosci. Lett., 92, 92-96.
16. KURZ, A.K., BULTMANN, R., DRIESSEN, B., VON KUGELGEN I. & STARKE, K. (1994). Release of ATP in rat vas deferens: origin and role of calcium. Naunyn-Schmied. Arch. Pharmacol., 350, 491-498.
17. KUSUNOKI, M., TANIYAMA, K. & TANAKA, C. (1984). Neurona; GABA release and GABA inhibition of ACh release in guinea-pig urinary bladder. Am. J. Physiol., 246, R502-R509.
18. LARA, H. & BASTOS-RAMOS, W. (1988). Glutamate and kainate effects on the noradrenergic neurons innervating the rat vas deferens. J. Neurosci. Res., 19, 239-244.
19. 1 adenosine receptors. Naunyn-Schmied. Arch. Pharmacol., 336, 204-210.
20. B receptors in detrusor strips from guinea-pig bladder dome. J. Auton. Pharmacol., 5, 55-64.
21. NARAHASHI, T. (1974). Chemicals as tools in the study of excitable membranes. Physiol. Rev., 54, 813-889.
22. PIN, J.P. & BOCKAERT, J. (1989). Two distinct mechanisms, differentially affected by excitatory amino acids, trigger GABA release from fetal mouse striatal neurons in primary culture. J. Neurosci., 9, 648-656.
23. QUME, M., WHITTON, P.S. & FOWLER, L.J. (1995). The effects of chronic treatment with the GABA transaminase inhibitors γ-vinyl-GABA and ethanolamine-O-sulphate on the in vivo release of GABA from rat hippocampus. J. Neurochem., 64, 2256-2261.
24. RUMP, L.C. & VON KUGELGEN, I. (1994). A study of ATP as a sympathetic cotransmitter in human saphenous vein. Br. J. Pharmacol., 111, 65-72.
25. SAWAKI, K., OUCHI, K., SATO, T. & KAWAGUCHI, M. (1995). Existence of gamma-aminobutyric acid and its biosynthetic and metabolic enzymes in rat salivary glands. Jpn. J. Pharmacol., 67, 359-363.
26. B receptor-mediated inhibition of serotonin release in the rat brain. Naunyn-Schmied. Arch. Pharmacol., 326, 99-105.
27. SNEDDON, P. & BURNSTOCK, G. (1984). Inhibition of excitatory junction potentials in guinea-pig vas deferens by α, β-methylene ATP: Further evidence for ATP and noradrenaline as co-transmitters. Eur. J. Pharmacol., 100, 85-95.
28. SNEDDON, P. & MACHALY, M. (1992). Regional variation in purinergic and adrenergic responses in isolated vas deferens of rat, rabbit and guinea pig. J. Auton. Pharmacol., 12, 421-428.
29. TAYLOR, D.A., WIESE, S., FAISON, E.P. & YARBROUGH, G.G. (1983). Pharmacological characterization of purinergic receptors in the rat vas deferens. J. Pharmacol. Exp. Ther., 224, 40-45.
30. TODOROV, L.D., BJUR, R.A. & WESTFALL, D.P. (1994). Temporal dissociation of the release of the sympathetic co-transmitters ATP and noradrenaline. Clin. Exp. Pharmacol. Physiol., 21, 931-932.
31. 1-receptors. Naunyn-Schmied. Arch. Pharmacol., 346, 187-196.
32. VON KUGELGEN, I., SPATH, L. & STARKE, K. (1992b). Adenosine but not an adenine nucleotide mediates tonic purinergic inhibition, as well as inhibition by glutamate, of noradrenergic release in rabbit brain cortex slices. Naunyn-Schmied Arch. Pharmacol., 346, 677-684.
33. 3H]-noradrenaline release in rabbit brain cortex slices. Br. J. Pharmacol., 110, 1544-1550.
34. 2-purinoceptor-mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens. Naunyn-Schmied. Arch. Pharmacol., 349, 125-132.
35. WATKINS, J.C., KROGSGAARD-LARSEN, P. & HONORE, T. (1990). Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends Neurosci., 11, 25-33.
36. WESTFALL, D.P., STITZEL, R.E. & ROWE, J.N. (1978). The postjunctional effects and neural release of purine compounds in the guinea-pig vas deferens. Eur. J. Pharmacol., 50, 27-38.
37. WHITE, H.L. (1981). Glutamate as a precursor of GABA in rat brain and peripheral tissues. In The Biological Effects of Glutamic Acid and its Derivatives. ed. Najjar, V.A., pp. 253-259. The Hague: Martinus, Nijhoff/Dr. W. Junk Publishers.